vs
汉瑞祥（HSIC）与希捷科技（STX）财务数据对比。点击上方公司名可切换其他公司
汉瑞祥的季度营收约是希捷科技的1.1倍（$3.4B vs $3.1B），希捷科技净利率更高（24.0% vs 2.9%，领先21.1%），希捷科技同比增速更快（44.1% vs 7.7%），希捷科技自由现金流更多（$953.0M vs $338.0M），过去两年希捷科技的营收复合增速更高（28.4% vs 4.1%）
汉瑞祥（Henry Schein, Inc.）是美国的医疗保健产品及服务分销商，业务覆盖全球33个国家和地区，是全球面向诊所类牙科及医疗从业者的最大医疗解决方案供应商。公司连续14年入选Ethisphere评选的「全球最具道德企业」榜单，2025年再次登榜。
希捷科技是全球知名的美国数据存储企业，1978年注册成立时名为舒加特科技，1979年正式开展业务，2010年起注册地变更为爱尔兰都柏林，运营总部设在美国加利福尼亚州弗里蒙特，面向全球市场提供专业的数据存储产品与解决方案。
HSIC vs STX — 直观对比
营收规模更大
HSIC
是对方的1.1倍
$3.1B
营收增速更快
STX
高出36.4%
7.7%
净利率更高
STX
高出21.1%
2.9%
自由现金流更多
STX
多$615.0M
$338.0M
两年增速更快
STX
近两年复合增速
4.1%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $3.4B | $3.1B |
| 净利润 | $101.0M | $748.0M |
| 毛利率 | 30.9% | 46.5% |
| 营业利润率 | 4.7% | 32.1% |
| 净利率 | 2.9% | 24.0% |
| 营收同比 | 7.7% | 44.1% |
| 净利润同比 | 7.4% | -23.8% |
| 每股收益（稀释后） | $0.85 | $3.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HSICSTX
| Q3 26 | — | $3.1B | ||
| Q1 26 | — | $2.8B | ||
| Q4 25 | $3.4B | $2.6B | ||
| Q3 25 | $3.3B | — | ||
| Q2 25 | $3.2B | $2.4B | ||
| Q1 25 | $3.2B | $2.2B | ||
| Q4 24 | $3.2B | $2.3B | ||
| Q3 24 | $3.2B | $2.2B |
净利润HSICSTX
| Q3 26 | — | $748.0M | ||
| Q1 26 | — | $593.0M | ||
| Q4 25 | $101.0M | $549.0M | ||
| Q3 25 | $101.0M | — | ||
| Q2 25 | $86.0M | $488.0M | ||
| Q1 25 | $110.0M | $340.0M | ||
| Q4 24 | $94.0M | $336.0M | ||
| Q3 24 | $99.0M | $305.0M |
毛利率HSICSTX
| Q3 26 | — | 46.5% | ||
| Q1 26 | — | 41.6% | ||
| Q4 25 | 30.9% | 39.4% | ||
| Q3 25 | 30.7% | — | ||
| Q2 25 | 31.4% | 37.4% | ||
| Q1 25 | 31.6% | 35.2% | ||
| Q4 24 | 31.1% | 34.9% | ||
| Q3 24 | 31.3% | 32.9% |
营业利润率HSICSTX
| Q3 26 | — | 32.1% | ||
| Q1 26 | — | 29.8% | ||
| Q4 25 | 4.7% | 26.4% | ||
| Q3 25 | 4.9% | — | ||
| Q2 25 | 4.7% | 23.2% | ||
| Q1 25 | 5.5% | 20.0% | ||
| Q4 24 | 4.9% | 21.0% | ||
| Q3 24 | 4.9% | 18.6% |
净利率HSICSTX
| Q3 26 | — | 24.0% | ||
| Q1 26 | — | 21.0% | ||
| Q4 25 | 2.9% | 20.9% | ||
| Q3 25 | 3.0% | — | ||
| Q2 25 | 2.7% | 20.0% | ||
| Q1 25 | 3.5% | 15.7% | ||
| Q4 24 | 2.9% | 14.5% | ||
| Q3 24 | 3.1% | 14.1% |
每股收益（稀释后）HSICSTX
| Q3 26 | — | $3.27 | ||
| Q1 26 | — | $2.60 | ||
| Q4 25 | $0.85 | $2.43 | ||
| Q3 25 | $0.84 | — | ||
| Q2 25 | $0.70 | $2.24 | ||
| Q1 25 | $0.88 | $1.57 | ||
| Q4 24 | $0.75 | $1.55 | ||
| Q3 24 | $0.78 | $1.41 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $156.0M | $1.1B |
| 总债务越低越好 | $2.3B | $3.9B |
| 股东权益账面价值 | $3.2B | — |
| 总资产 | $11.2B | $8.9B |
| 负债/权益比越低杠杆越低 | 0.71× | — |
8季度趋势，按日历期对齐
现金及短期投资HSICSTX
| Q3 26 | — | $1.1B | ||
| Q1 26 | — | $1.0B | ||
| Q4 25 | $156.0M | $1.1B | ||
| Q3 25 | $136.0M | — | ||
| Q2 25 | $145.0M | $891.0M | ||
| Q1 25 | $127.0M | $814.0M | ||
| Q4 24 | $122.0M | $1.2B | ||
| Q3 24 | $126.0M | $1.2B |
总债务HSICSTX
| Q3 26 | — | $3.9B | ||
| Q1 26 | — | — | ||
| Q4 25 | $2.3B | — | ||
| Q3 25 | $2.2B | — | ||
| Q2 25 | $2.1B | — | ||
| Q1 25 | $2.0B | — | ||
| Q4 24 | $1.8B | — | ||
| Q3 24 | $1.9B | — |
股东权益HSICSTX
| Q3 26 | — | — | ||
| Q1 26 | — | $459.0M | ||
| Q4 25 | $3.2B | $-63.0M | ||
| Q3 25 | $3.4B | — | ||
| Q2 25 | $3.4B | $-453.0M | ||
| Q1 25 | $3.3B | $-829.0M | ||
| Q4 24 | $3.4B | $-1.1B | ||
| Q3 24 | $3.5B | $-1.3B |
总资产HSICSTX
| Q3 26 | — | $8.9B | ||
| Q1 26 | — | $8.7B | ||
| Q4 25 | $11.2B | $8.4B | ||
| Q3 25 | $11.1B | — | ||
| Q2 25 | $10.9B | $8.0B | ||
| Q1 25 | $10.5B | $7.6B | ||
| Q4 24 | $10.2B | $8.0B | ||
| Q3 24 | $10.6B | $8.0B |
负债/权益比HSICSTX
| Q3 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | 0.71× | — | ||
| Q3 25 | 0.64× | — | ||
| Q2 25 | 0.61× | — | ||
| Q1 25 | 0.59× | — | ||
| Q4 24 | 0.54× | — | ||
| Q3 24 | 0.54× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $381.0M | $2.4B |
| 自由现金流经营现金流 - 资本支出 | $338.0M | $953.0M |
| 自由现金流率自由现金流/营收 | 9.8% | 30.6% |
| 资本支出强度资本支出/营收 | 1.3% | — |
| 现金转化率经营现金流/净利润 | 3.77× | 3.17× |
| 过去12个月自由现金流最近4个季度 | $573.0M | — |
8季度趋势，按日历期对齐
经营现金流HSICSTX
| Q3 26 | — | $2.4B | ||
| Q1 26 | — | — | ||
| Q4 25 | $381.0M | $532.0M | ||
| Q3 25 | $174.0M | — | ||
| Q2 25 | $120.0M | $508.0M | ||
| Q1 25 | $37.0M | $259.0M | ||
| Q4 24 | $204.0M | $221.0M | ||
| Q3 24 | $151.0M | $95.0M |
自由现金流HSICSTX
| Q3 26 | — | $953.0M | ||
| Q1 26 | — | — | ||
| Q4 25 | $338.0M | $427.0M | ||
| Q3 25 | $141.0M | — | ||
| Q2 25 | $88.0M | $425.0M | ||
| Q1 25 | $6.0M | $216.0M | ||
| Q4 24 | $168.0M | $150.0M | ||
| Q3 24 | $117.0M | $27.0M |
自由现金流率HSICSTX
| Q3 26 | — | 30.6% | ||
| Q1 26 | — | — | ||
| Q4 25 | 9.8% | 16.2% | ||
| Q3 25 | 4.2% | — | ||
| Q2 25 | 2.7% | 17.4% | ||
| Q1 25 | 0.2% | 10.0% | ||
| Q4 24 | 5.3% | 6.5% | ||
| Q3 24 | 3.7% | 1.2% |
资本支出强度HSICSTX
| Q3 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | 1.3% | 4.0% | ||
| Q3 25 | 1.0% | — | ||
| Q2 25 | 1.0% | 3.4% | ||
| Q1 25 | 1.0% | 2.0% | ||
| Q4 24 | 1.1% | 3.1% | ||
| Q3 24 | 1.1% | 3.1% |
现金转化率HSICSTX
| Q3 26 | — | 3.17× | ||
| Q1 26 | — | — | ||
| Q4 25 | 3.77× | 0.97× | ||
| Q3 25 | 1.72× | — | ||
| Q2 25 | 1.40× | 1.04× | ||
| Q1 25 | 0.34× | 0.76× | ||
| Q4 24 | 2.17× | 0.66× | ||
| Q3 24 | 1.53× | 0.31× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HSIC
| Global Dental Merchandise | $1.2B | 35% |
| Global Medical | $1.1B | 31% |
| Global Dental Equipment | $536.0M | 16% |
| Global Specialty Products | $422.0M | 12% |
| Global Technology | $173.0M | 5% |
| Global Value Added Services | $64.0M | 2% |
| Equity Method Investee | $14.0M | 0% |
STX
暂无分部数据
